Search
Patexia Research
Case number 1:19-cv-12045

BAUSCH HEALTH IRELAND LIMITED et al v. GLENMARK PHARMACEUTICALS LIMITED > Documents

Date Field Doc. No.Description (Pages)
Sep 5, 2019 N/A Terminated Case (0)
Docket Text: ***Civil Case Terminated. (dmr)
Sep 4, 2019 9 Order (2)
Docket Text: LETTER ORDER Directing Plaintiffs to take the lead on coordinating the parties' meet and confer session(s), etc. Signed by Magistrate Judge Joel Schneider on 9/4/2019. (rss, )
Sep 4, 2019 10 Notice of Voluntary Dismissal (aty) (2)
Docket Text: NOTICE of Voluntary Dismissal by ASSERTIO THERAPEUTICS INC., BAUSCH HEALTH IRELAND LIMITED (DENI, WILLIAM)
Sep 3, 2019 8 Order Initial Scheduling Conference (Camden) (6)
Docket Text: Order Initial Conference set for 10/16/2019 10:00 AM in Room 2060 before Magistrate Judge Joel Schneider.. Signed by Magistrate Judge Joel Schneider on 9/3/2019. (rss, )
Aug 6, 2019 7 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE Returned Executed by BAUSCH HEALTH IRELAND LIMITED, ASSERTIO THERAPEUTICS INC.. GLENMARK PHARMACEUTICALS LIMITED waiver sent on 7/31/2019, answer due 9/30/2019. (DENI, WILLIAM)
Jul 16, 2019 6 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by J. BRUGH LOWER on behalf of ASSERTIO THERAPEUTICS INC., BAUSCH HEALTH IRELAND LIMITED (LOWER, J.)
May 3, 2019 N/A Notice of Judicial Preferences (0)
Docket Text: Notice of Judicial Preferences. Click here for the Judge's Individual Procedure Requirements. (ssp, )
May 3, 2019 4 Summons Issued (2)
Docket Text: SUMMONS ISSUED as to GLENMARK PHARMACEUTICALS LIMITED. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (ssp, )
May 3, 2019 5 AO120 Patent/Trademark Form (1)
Docket Text: AO120 Patent Form filed. (ssp, )
May 1, 2019 N/A Add and Terminate Judges (0)
Docket Text: Judge Renee Marie Bumb and Magistrate Judge Joel Schneider added. (dd, )
May 1, 2019 1 Complaint (13)
May 1, 2019 1 Exhibit 1 (10)
May 1, 2019 1 Exhibit 2 (13)
May 1, 2019 1 Exhibit 3 (15)
May 1, 2019 1 Exhibit 4 (40)
May 1, 2019 1 Civil Cover Sheet (1)
May 1, 2019 1 L. Civ. R. 11.2 Certification (1)
May 1, 2019 2 Corporate Disclosure Statement (aty) (1)
Docket Text: Corporate Disclosure Statement by BAUSCH HEALTH IRELAND LIMITED identifying Bausch Health Companies Inc. as Corporate Parent.. (DENI, WILLIAM)
May 1, 2019 3 Corporate Disclosure Statement (aty) (1)
Docket Text: Corporate Disclosure Statement by ASSERTIO THERAPEUTICS INC. identifying BlackRock, Inc. as Corporate Parent.. (DENI, WILLIAM)
May 1, 2019 1 Main Document (13)
Docket Text: COMPLAINT against GLENMARK PHARMACEUTICALS LIMITED ( Filing and Admin fee $ 400 receipt number 0312-9633488), filed by BAUSCH HEALTH IRELAND LIMITED, ASSERTIO THERAPEUTICS INC.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Civil Cover Sheet, # (6) L. Civ. R. 11.2 Certification)(DENI, WILLIAM)
May 1, 2019 1 Complaint* (1)
Menu